NCT03934632 is a NA clinical trial of Postabsorptive in Healthy, sponsored by University of Exeter.

Who is sponsoring NCT03934632?

NCT03934632 is sponsored by University of Exeter.

What drugs are being tested in NCT03934632?

Interventions in NCT03934632: Postabsorptive, Postprandial, Immobilisation.

Is NCT03934632 still recruiting?

NCT03934632 is currently completed. Last updated 22 March 2023.

Last reviewed 2023-03-22 · How we verify

NCT03934632

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males

Completed NA Last updated 22 March 2023

What this trial tests

NA trial testing Postabsorptive in Healthy in 24 participants. Completed in 9 January 2023.

Timeline

15 April 2019

Primary endpoint
17 March 2020

9 January 2023

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	24
Start date	15 April 2019
Primary completion	17 March 2020
Estimated completion	9 January 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Postabsorptive
Postprandial
Immobilisation

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Exeter

Who can join

Adults 18 to 40, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will seek the quantify the simultaneous muscle protein synthesis and breakdown response with and without amino acid provision in humans following 2 days of immobilisation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Short-term disuse does not affect postabsorptive or postprandial muscle protein fractional breakdown rates.
Pavis GF, Abdelrahman DR, Murton AJ, Wall BT, et al · · 2023 · cited 16× · PMID 37431714 · DOI 10.1002/jcsm.13284

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Exeter trials

Trials by the same sponsor.

NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03934632 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Exeter
Last refreshed: 22 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03934632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing